Cancer center – Page 4 – Communicable Diseases Research

COVID-19 Vaccine Safety in Cancer Patients: A Single Centre Experience

Article

Published on 2021-07-162022-10-31
Journal: Cancers [Category] COVID-19,

Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer center

Research article

Published on 2021-07-012022-10-05
Journal: Gynecologic oncology [Category] 치료법,

COVID-19 Pandemic: Huge Stress Test for Health System Could Be a Great Opportunity to Update the Workflow in a Modern Surgical Pathology

Article

Published on 2021-06-302022-10-31
Journal: Cancers [Category] COVID-19,

[키워드] acute respiratory syndrome affected applied Atypical average biopsy calculated Cancer Cancer center Cancer screening change changes in characterized Contagion Containment coronavirus COVID-19 COVID-19 pandemic cytological death deaths decrease Department Diagnosis diagnostic disease feasible First wave Health management human-to-human transmission infection rate INT introduced IRCCS Italian lockdown lombardy manuscript measure Metrics molecular not affect occurred opportunity outbreak pathology performed Pneumonia preventive measures reduce Region released required SARS-CoV-2 simple Spread surgical System TAT Test the patient took place Variation Wuhan, China
[DOI] 10.3390/cancers13133283 PMC 바로가기 [Article Type] Article

Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers

Article

Published on 2021-06-112022-10-31
Journal: Cancers [Category] COVID-19,

[키워드] accompanied age analyzed anti-cancer treatment Asymptomatic Bacterial infection Cancer Cancer center cancer patient Cancer patients cancer treatment center clinical Clinical course co-morbidities Contact tracing contribute Course courses COVID-19 COVID-19 cases COVID-19 pandemic COVID-19 symptom Critical Deterioration diagnosed diagnostic died Follow-up hematologic heterogenous IMPROVE increased risk investigated knowledge management Mild Modification neoplasm oncologist oncology Patient patients patients with SARS-CoV-2 performance status predominant progressive disease provide risk RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 scenarios scenario secondary significantly increased simple Surveillance survival rate survivor therapeutic strategy therapy Treatment undergo
[DOI] 10.3390/cancers13122917 PMC 바로가기 [Article Type] Article

SARS-CoV-2 nosocomial infection: Real-world results of environmental surface testing from a large tertiary cancer center

SARS-CoV-2 병원 감염: 대규모 3차 암 센터에서 환경 표면 테스트의 실제 결과

Article

Published on 2021-06-012022-09-11
Journal: Cancer [Category] SARS, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed Antigen antigen receptor Cancer Cancer center Care Chain Reaction clinics Consensus contaminated surface contaminated surfaces Contamination coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 transmission environmental surface testing equipment evaluated examined Health Organization hematologic hematologic malignancies incidence infection control Laboratory leukemia lymphoma Medical care multitude nosocomial Nosocomial infection oncology Patient Patients with cancer performed positive Positive test potential risk protocol protocols Quality assurance Quality improvement receptor reverse transcriptase reverse transcriptase-polymerase chain reaction Sample SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 viral RNA seeking severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shown solid tumors surface T-cell tested Transmission Viral RNA Viral transmission virus World Health Organization
[DOI] 10.1002/cncr.33453 PMC 바로가기 [Article Type] Article

Real-World Data on the Impact of COVID-19 on Endoscopic Procedural Delays

내시경 절차 지연에 대한 COVID-19의 영향에 대한 실제 데이터

Article

Published on 2021-06-012022-09-12
Journal: Clinical and Translational Gastroenterology [Category] MERS, SARS, 진단,

Genitourinary Medical Oncology Expert Opinion Survey Regarding Treatment Management in the COVID-19 Pandemic

Research article

Published on 2021-06-012022-10-05
Journal: Clinical genitourinary cancer [Category] SARS, 치료법,

Prospective Observational COVID-19 Screening and Monitoring of Asymptomatic Cancer Center Health-Care Workers with a Rapid Serological Test

Brief Report

Published on 2021-05-282022-10-31
Journal: Diagnostics [Category] COVID-19,

What Proportion of Patients with Bone and Soft Tissue Tumors Contracted Coronavirus-19 and Died From Surgical Procedures During the Initial Period of the COVID-19 Pandemic? Results From the Multicenter British Orthopaedic Oncology Society Observational Study

Observational Study

Published on 2021-05-012022-10-05
Journal: Clinical orthopaedics and related research [Category] SARS, 임상,

[키워드] 48 hour addition adjuvant therapy Admission age agency analyzed association Asymptomatic benefit bone Cancer Cancer center cancer treatment Care Chemotherapy clinician Complication contracting the virus Coronavirus 2019 COVID-19 COVID-19 in patient COVID-19-related complications detrimental eight England Factor FIVE Follow-up Future help hospital Hospital stay identify Increased increased mortality increased risk initial knowledge Level likelihood lower risk management mandatory measure median men Mortality Musculoskeletal National National Health Service Odds ratio oncology outcome outcomes pandemic Patient patients died PCR testing performed Period potential risk Primary outcome procedure Radiation reduce Result retrospective risk secondary outcome Society Soft surgeon surgical Surgical Procedure susceptibility tested the median therapeutic therapy tissue treated Treatment Tumor undergo United Kingdom were used
[DOI] 10.1097/CORR.0000000000001568 PMC 바로가기 [Article Type] Observational Study

Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France

Original Research

Published on 2021-04-172022-10-31
Journal: ESMO open [Category] COVID-19, MERS, SARS,